Se încarcă compania
Just reported
Q3 2026 results
From OPKO Health's results release of 4 noiembrie 2026; its quarterly report has since been filed.
Revenue
Actual
65,4M USD
+16 % y/y
-60 % q/qGuided
—
No guide given
EPS, GAAP
Actual
-0,07 USD
Guided
—
No guide given
Operating income, GAAP
Actual
-31,4M USD
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes OPKO Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.259,4B USDA+
IDXXIdexx Laboratories Inc.55,5B USDA+
IQVIQVIA Holdings Inc.43,7B USDA
ILMNIllumina, Inc.31,3B USDA+
LHLabcorp Holdings Inc.30,1B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct. 2026CBGraded C, now B
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 oct. 2026CAGraded C, now A
Situațiile financiare complete →
Construit din raportările proprii ale OPKO Health, Inc. la Comisia pentru Valori Mobiliare și Burse a SUA (SEC). Cifrele sunt cele raportate, iar istoricul pe acțiune este recalculat la baza de acțiuni de azi. Aceasta descrie o afacere — nu este consultanță de investiții și nu este o recomandare de cumpărare sau vânzare.
